CN107353318A - The preparation method of 6 dehydrogenation nandrolone acetates - Google Patents

The preparation method of 6 dehydrogenation nandrolone acetates Download PDF

Info

Publication number
CN107353318A
CN107353318A CN201710564057.8A CN201710564057A CN107353318A CN 107353318 A CN107353318 A CN 107353318A CN 201710564057 A CN201710564057 A CN 201710564057A CN 107353318 A CN107353318 A CN 107353318A
Authority
CN
China
Prior art keywords
reaction
preparation
dehydrogenations
nandrolone
purity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710564057.8A
Other languages
Chinese (zh)
Inventor
李栋
张谦
潘高峰
卢方欣
系祖斌
贺君
贺一君
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Common Pharmaceutical Co., Ltd.
Original Assignee
HUBEI GONGTONG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Hubei University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUBEI GONGTONG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd, Hubei University of Technology filed Critical HUBEI GONGTONG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority to CN201710564057.8A priority Critical patent/CN107353318A/en
Publication of CN107353318A publication Critical patent/CN107353318A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters

Abstract

Steroid drugs Tibolone is the medicine for treating climacteric or Post operation menopausal women disorder.It with the β diacetates of 3,5 estradiene 3,17 is that raw material is sloughed by bromine addition and completes the displacement of alkene that this route, which is, synthesizes 6 dehydrogenation nandrolone acetates, this medicine is one of important as precursors medicine of Tibolone, yield 85%.The invention provides simple and easy to operate, high yield 6 dehydrogenation nandrolone acetates steroid drugs of synthesis a method.

Description

The preparation method of 6- dehydrogenation nandrolone acetates
Technical field
The invention belongs to pharmaceutical synthesis field, and in particular to the preparation method of 6- dehydrogenation nandrolone acetates steroid drugs.
Background technology
Steroid drugs plays a significant role in terms of disease preventing and treating, including medicine, veterinary drug and agricultural chemicals, what foreign countries had listed Steroidal drug has a kind more than 400, the existing kind in China only account for thirdly point one, also have very big gap from advanced international standard, In terms of steroid drugs research and development compared with advanced country in the world also a certain distance, be mainly shown as that steroid drugs synthesizes Step is more, and reaction is complicated, and the distant effect of group is fairly obvious, and yield is low, particularly isolates and purifies difficulty.Many steroid drugs The research of steroid drugs particularly with high content of technology goes to research and develop in China or blank, urgent need.
Steroid drugs Tibolone is the medicine for treating climacteric or Post operation menopausal women disorder.Because of its tool There are weak estrogen, progestational hormone sample activity.It can make the hypothalamic hypophyseal system of climacteric women stable, can substantially suppress blood plasma Follicle-stimulating hormone (FSH) is horizontal.It is lighter to the inhibition level of metakentrin, prolactin(PRL is not influenceed, has suppression ovulation to make to the women of child-bearing age With hormone replacement therapy (HRT) medicine being approved as quickly, for alleviating menopause symptom after postmenopausal women.Steroid drugs Tibolone eliminates climacteric syndrome shape with its complementing estrogen, prevents from losing sad without causing uterus canceration and breast canceration Outstanding advantages, turn into the choice drug for improving climacteric women quality of life.6- dehydrogenation nandrolone acetates are steroid drugs for vigorous One of important as precursors medicine of dragon, the synthesis of the medicine is a committed step.
The content of the invention
The purpose of the present invention is to be directed to above-mentioned present situation, it is desirable to provide a kind of technical process is simple, mild condition, and yield is high The preparation method of 6- dehydrogenation nandrolone acetates.
A kind of preparation method of 6- dehydrogenations nandrolone acetate, its step are:In reaction vessel, by compound 3,5- female steroids Diene -3,17 β-diacetate is dissolved in the mixed liquor of DMF and water, and at -10 DEG C to -5 DEG C, magnetic force stirs maintenance system reaction temperature Mix, the NBS solution being dissolved in DMF is added dropwise, while maintenance reaction temperature after the completion of feeding intake, is warming up to 25 below 0 DEG C DEG C, with TLC detections reaction, (TLC, which is otherwise known as, does thin-layered chromatography, and silica gel is coated on support plate, and silica gel is stationary phase, at this We utilize reactant in organic phase and production by the use of properly mixed ethyl acetate and petroleum ether as solvent flow phase in secondary experiment The polarity of thing is different, and absorption affinity is also different, so the different organic matters in organic phase will stop in the presence of solvent Onboard different position.We are monitored whether reaction terminates using TLC during reaction, are inhaled respectively with capillary Two raw materials and reaction solution are taken, liquid dot is equably got in suitable position on silica gel plate, deploys in cylinder is opened up, waits flowing Suitable height is mutually climbed to, silica gel plate see whether that the point of product occurs under uviol lamp).Question response liquid is in TLC On without raw material point occur thinking that reaction is completed.A certain amount of sodium carbonate is put into system first, treats that sodium carbonate is complete in reaction solution After fully dissolved, then to a certain amount of sodium bromide of system input, after the completion of feeding intake, reaction system is warming up to 45 DEG C, maintains this Temperature continues to react half an hour, then after being gradually heating to 80 DEG C, maintains this temperature to continue reaction a period of time until intermediate product The i.e. reaction of 6- dehydrogenation nandrolone acetic acid esterified products is fully converted to terminate.Reaction stops heating after terminating, and reaction system is cooled down To 25 DEG C, stop stirring, acetic acid aqueous solution (V is added to reaction systemAcetic acid:VWater=1:5), after the completion of addition, stirring reaction system For a period of time, then add the acetic acid aqueous solution of equivalent, continue stirring reaction 12h, after after solid is separated out, not leaked with Bu Shi Struggle against filtration product, cleans filter cake with the isopropanol of cold (0 DEG C to 5 DEG C) and the mixed liquor of purified water, obtains pale yellow powder, dries Product produces 6- dehydrogenation nandrolone acetate net products to constant weight.
Preferably, the mass ratio between 3,5- estradienes -3,17 β-diacetate, DMF, water three is (15-20): (50-70):1, preferably 16:60:1.
Preferably, NBS is dissolved in the DMF of 3 times of quality.
Preferably, the quality of sodium carbonate is the 5-10% of 3,5- estradienes -3,17 β-diacetate, preferably 5%.
Preferably, the quality of sodium bromide is the half of sodium carbonate.
Preferably, the concentration of acetic acid aqueous solution is VAcetic acid:VWater=1:5, mixing time is half after adding acetic acid solution for the first time Hour.
Preferably, the heating in course of reaction uses oil bath heating, and reaction vessel bottom is immersed in silicone oil, submergence It is that silicone oil is highly higher than reaction solution height in reaction vessel.
Preferably, the mass ratio of isopropyl alcohol and water is 2:3.
Preferably, the purity that the purity of 3,5- estradienes -3,17 β-diacetate is 98%, DMF is 99.5%, NBS Purity is 99%, and the purity of sodium carbonate is 99.8%, and the purity of sodium bromide is 99%, and the purity of acetic acid is 99.5%, isopropanol Purity be 99.7%.
Preferably, magnetic stirring apparatus rotating speed is 500 turns/s, but not limited to this scope, those skilled in the art can be according to need It is adjusted rotating speed.
The advantages of the present invention:
The advantages that operation technique of the present invention is simple, mild condition, higher and environmentally friendly yield.The 6- of synthesis is gone Hydrogen nandrolone acetates steroid drugs has important application value in medicine, veterinary drug and pesticide field.The steroid drugs is also One of important as precursors medicine of Tibolone.
Brief description of the drawings
The proton nmr spectra of Fig. 1 products of the present invention;
The carbon-13 nmr spectra of Fig. 2 products of the present invention;
The infrared spectrum of Fig. 3 products of the present invention;
Wherein, proton nmr spectra INSTRUMENT MODEL:Bruker DPX-400,1H NMR(400MHz,CDCl3);Nuclear magnetic resonance Carbon composes INSTRUMENT MODEL:Bruker DPX-400,13C NMR(100MHz,CDCl3);Infrared spectrum INSTRUMENT MODEL:Nicolet IS50FT-IR。
Embodiment
The present invention reaction expression be
The present invention is put into No. 8 magnetons in 100mL three-neck flask, by compound 3,5- estradienes -3,17 β - Diacetate (1g) is dissolved in the mixed liquor of DMF (3.78g) and water (62mg), and maintenance system reaction temperature is at -10 DEG C to -5 DEG C. At a temperature of this, be added dropwise NBS (0.535g) solution being dissolved in DMF (1.65g), at the same maintenance reaction temperature 0 DEG C with Under.After the completion of feeding intake, mixture is warming up to 25 DEG C in 30min, detected and reacted with TLC.Question response complete after, first to System input sodium carbonate (0.495g), sodium bromide (0.255g) is put into after abundant reaction, then to system, after the completion of feeding intake, Reaction system is warming up to 40 DEG C, at this temperature maintenance reaction half an hour, then in one hour, is gradually heating to 80 DEG C, Continue to react 3h until reaction terminates.Reaction stops heating after terminating, and reaction system is cooled into 25 DEG C, first to reaction system Acetic acid aqueous solution (acetic acid 0.443g, water 2.775g) is added, the not stirring reaction liquid when adding, after the completion of addition, stirring reaction System 5min, the acetic acid aqueous solution of equivalent is then added, continue to be stirred overnight.After gradually solid is separated out, with 500mL cloth Family name's funnel filtration product, clean filter cake 3 times with the mixed liquor of cold isopropanol (0.2g) and purified water (0.3g), obtain faint yellow Powder, desciccate to constant weight, produce 6- dehydrogenation nandrolone acetate net products, yield 85%.
It is the characterization result of product of the present invention below, it is recorded unanimously with document, and it is pure to be defined as 6- dehydrogenation nandrolone acetates Product.
Fig. 1 is product proton nmr spectra1H NMR(400MHz,CDCl3):δ0.88(s,3H),1.10–1.18(m,1H), 1.20–1.34(m,3H),1.43–1.62(m,3H),1.80–1.83(m,2H),2.06(s,3H),2.12–2.39(m,6H), 2.52-2.56 (m, 1H), 4.65 (t, J=8.32Hz, 1H), 5.78 (s, 1H), 6.16-6.22 (m, 2H).
Fig. 2 is product carbon-13 nmr spectra13C NMR(100MHz,CDCl3):δ11.8,21.1,22.9,25.0,26.9, 27.3,36.4,37.7,40.8,41.1,43.4,45.9,47.7,82.1,124.4,128.8,141.4,158.8,171.1, 200.0。
Fig. 3 is product infrared spectrum IR (cm-1):1726,1652,1255,1117。

Claims (10)

  1. A kind of 1. preparation method of 6- dehydrogenations nandrolone acetate, it is characterised in that:In reaction vessel, by compound 3,5- female steroids Diene -3,17 β-diacetate is dissolved in the mixed liquor of DMF and water, and at -10 DEG C to -5 DEG C, magnetic force stirs maintenance system reaction temperature Mix, the NBS solution being dissolved in DMF is added dropwise, while maintenance reaction temperature after the completion of feeding intake, is warming up to 25 below 0 DEG C DEG C, detected and reacted with TLC, after question response is completed, put into a certain amount of sodium carbonate to system first, treat sodium carbonate in reaction solution In be completely dissolved after, then to system put into a certain amount of sodium bromide, after the completion of feeding intake, reaction system be warming up to 35-45 DEG C, Maintain this temperature to continue to react half an hour, after being gradually heating to 75-85 DEG C, maintain this temperature to continue to react, reaction stops after terminating Only heat, reaction system is cooled to 20-25 DEG C, stops stirring, the acetic acid that half volume is added to reaction system is water-soluble Liquid, after the completion of addition, stirring reaction system for a period of time, then adds the acetic acid aqueous solution of equivalent, continues stirring reaction 12h, after no longer solid is separated out, with filtered on buchner funnel product, the mixed liquor with 0 DEG C to 5 DEG C of isopropanol and purified water is clear Filter wash cake, pale yellow powder is obtained, desciccate to constant weight, produces 6- dehydrogenation nandrolone acetate net products.
  2. A kind of 2. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:3,5- female steroids two Mass ratio between the β of alkene-3,17-diacetate, DMF, water three is (15-20):(50-70):1, preferably 16:60:1.
  3. A kind of 3. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:NBS is dissolved in 3 In the DM F of times quality.
  4. A kind of 4. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:The matter of sodium carbonate Amount is the 5-10% of 3,5- estradienes -3,17 β-diacetate, preferably 5%.
  5. A kind of 5. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:The matter of sodium bromide Amount is the half of sodium carbonate.
  6. A kind of 6. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:Acetic acid aqueous solution Concentration be V acetic acid:V water=1:5, mixing time is half an hour after adding acetic acid solution for the first time.
  7. A kind of 7. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:In course of reaction Heating use oil bath heating, reaction vessel bottom is immersed in silicone oil, submergence be silicone oil highly be higher than reaction vessel in Reaction solution height.
  8. A kind of 8. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:Isopropyl alcohol and water Mass ratio be 2:3.
  9. A kind of 9. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:3,5- female steroids two The purity that the purity of alkene -3,17 β-diacetate is 98%, DMF is that 99.5%, NBS purity is 99%, and the purity of sodium carbonate is 99.8%, the purity of sodium bromide is 99%, and the purity of acetic acid is 99.5%, and the purity of isopropanol is 99.7%.
  10. A kind of 10. preparation method of 6- dehydrogenations nandrolone acetate according to claim 1, it is characterised in that:Magnetic agitation Device rotating speed is 500 turns/s.
CN201710564057.8A 2017-07-12 2017-07-12 The preparation method of 6 dehydrogenation nandrolone acetates Pending CN107353318A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710564057.8A CN107353318A (en) 2017-07-12 2017-07-12 The preparation method of 6 dehydrogenation nandrolone acetates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710564057.8A CN107353318A (en) 2017-07-12 2017-07-12 The preparation method of 6 dehydrogenation nandrolone acetates

Publications (1)

Publication Number Publication Date
CN107353318A true CN107353318A (en) 2017-11-17

Family

ID=60293270

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710564057.8A Pending CN107353318A (en) 2017-07-12 2017-07-12 The preparation method of 6 dehydrogenation nandrolone acetates

Country Status (1)

Country Link
CN (1) CN107353318A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108047299A (en) * 2017-12-29 2018-05-18 广西万德药业有限公司 The preparation method of canrenone important intermediate
CN114634542A (en) * 2022-03-30 2022-06-17 湖北武当安泰药业有限公司 Preparation method of dehydronandrolone acetate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104292285A (en) * 2014-09-30 2015-01-21 湖北三晶生物科技有限公司 Process for synthesizing high-content dehydronandrolon acetate
WO2015181116A1 (en) * 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015181116A1 (en) * 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
CN104292285A (en) * 2014-09-30 2015-01-21 湖北三晶生物科技有限公司 Process for synthesizing high-content dehydronandrolon acetate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
饶志威: "《脱氢诺龙醋酸酯的合成工艺研究》", 《中国药物化学杂志》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108047299A (en) * 2017-12-29 2018-05-18 广西万德药业有限公司 The preparation method of canrenone important intermediate
CN108047299B (en) * 2017-12-29 2021-11-09 广西万德药业有限公司 Preparation method of important intermediate of canrenone
CN114634542A (en) * 2022-03-30 2022-06-17 湖北武当安泰药业有限公司 Preparation method of dehydronandrolone acetate
CN114634542B (en) * 2022-03-30 2022-11-25 湖北武当安泰药业有限公司 Preparation method of dehydronandrolone acetate

Similar Documents

Publication Publication Date Title
WO2021258723A1 (en) Method for synthesizing lithocholic acid with ba as raw material
US3562260A (en) 2-carbonyl-estratrienes and method of their preparation
JPS5946299A (en) 11 beta- and 2-substituted novel 19-norsteroids, manufacture, use as drug, composition and novel intermediates
CN104262442B (en) The preparation method of Progesterone
CN109776644B (en) Synthesis method of progesterone
CN106866766B (en) The preparation method and preparation system of a kind of medroxyprogesterone acetate
WO2021012673A1 (en) Method for preparing trenbolone acetate
CN107353318A (en) The preparation method of 6 dehydrogenation nandrolone acetates
CN100422204C (en) 7-keto deoxy epiandrosterone and its acetate synthesizing method
WO2021012671A1 (en) Highly efficient preparation method for progesterone with low pollution
CN106831923B (en) A kind of preparation method of chenodeoxycholic acid
CN109422642A (en) Refining methd, the production method and equipment of pharmaceutical grade sodium benzoate of benzoic acid
CN101560237A (en) 14beta-hydro6beta,7beta,15beta,16beta-dimethylene-3-oxo-17beta-pregn-4-ene-21,17-carbolactone and synthesis method thereof
CN110204585A (en) A kind of synthetic method of progesterone
CN109503691A (en) A kind of synthetic method of 5 α-androstane -3,17- diketone
CN107188916A (en) A kind of preparation method of 6 dehydrogenation nandrolone acetate
CN115466300A (en) Cholic acid intermediate A7 and synthesis method thereof
CN107200762A (en) The preparation method of the β diacetates of 3,5 estradiene 3,17
CN109369760B (en) Method for preparing dehydromethyltestosterone
CN104059118B (en) The method that 4-alkene-3-ketone is 3 Alpha-hydroxy-5 β-hydrogen A/B cis-structure in stereo selectivity one step reduction steroid backbone
CN104788529B (en) The preparation method of 5 α-chloro-androstane-6 β, 19-epoxy-3,17-diketone
CN109627275A (en) A kind of bis- dehydrogenation -17a- hydroxyl progesterone product preparation methods of 1,6-
CN107011403B (en) A kind of preparation method for improving cholesterol purity
Nussbaum et al. Some substances derived from ruscogenin
Klimstra et al. Anabolic agents. A-ring oxygenated androstane derivatives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20181205

Address after: 442700 Baiguoshu Lute No. 1, Shuidu Industrial Park, Danjiangkou Economic Development Zone, Shiyan City, Hubei Province

Applicant after: Hubei Gongtong Biological Science & Technology Co., Ltd.

Address before: 442700 Baiguoshu Lute No. 1, Shuidu Industrial Park, Danjiangkou Economic Development Zone, Shiyan City, Hubei Province

Applicant before: Hubei Gongtong Biological Science & Technology Co., Ltd.

Applicant before: Hubei Industry University

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20190319

Address after: 441400 Gaokeng Group, Xiaohe Town, Yicheng City, Xiangfan City, Hubei Province

Applicant after: Hubei Common Pharmaceutical Co., Ltd.

Address before: 442700 Baiguoshu Lute No. 1, Shuidu Industrial Park, Danjiangkou Economic Development Zone, Shiyan City, Hubei Province

Applicant before: Hubei Gongtong Biological Science & Technology Co., Ltd.

TA01 Transfer of patent application right
RJ01 Rejection of invention patent application after publication

Application publication date: 20171117

RJ01 Rejection of invention patent application after publication